Eurofins: Purchases of Own Shares From April 7th to April 11th 2025

Realtime	Geld	Brief	Zeit
	54,36	54,84	24.04.
	54,36	54,64	07:08

Realtime

Geld

Brief

Zeit

54,36

54,84

24.04.

54,36

54,64

07:08

Eurofins: Purchases of Own Shares From April 7th to April 11th 2025

Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer	Identity code of the Issuer	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares	Market (MIC Code)
EUROFINS	529900JEHFM47DYY3S57	07/03/2025	FR0014000MR3	117,949	46.5566	XPAR
EUROFINS	529900JEHFM47DYY3S57	07/03/2025	FR0014000MR3	57,724	46.5835	CEUX
EUROFINS	529900JEHFM47DYY3S57	07/03/2025	FR0014000MR3	8,118	46.5843	TQEX
EUROFINS	529900JEHFM47DYY3S57	07/03/2025	FR0014000MR3	8,818	46.5950	AQEU
EUROFINS	529900JEHFM47DYY3S57	08/03/2025	FR0014000MR3	119,027	47.0631	XPAR
EUROFINS	529900JEHFM47DYY3S57	08/03/2025	FR0014000MR3	60,338	47.1450	CEUX
EUROFINS	529900JEHFM47DYY3S57	08/03/2025	FR0014000MR3	8,485	47.1454	TQEX
EUROFINS	529900JEHFM47DYY3S57	08/03/2025	FR0014000MR3	8,737	47.1471	AQEU
EUROFINS	529900JEHFM47DYY3S57	09/03/2025	FR0014000MR3	119,765	46.7822	XPAR
EUROFINS	529900JEHFM47DYY3S57	09/03/2025	FR0014000MR3	61,069	46.7989	CEUX
EUROFINS	529900JEHFM47DYY3S57	09/03/2025	FR0014000MR3	8,637	46.8098	TQEX
EUROFINS	529900JEHFM47DYY3S57	09/03/2025	FR0014000MR3	8,808	46.8186	AQEU
EUROFINS	529900JEHFM47DYY3S57	10/03/2025	FR0014000MR3	106,780	47.3397	XPAR
EUROFINS	529900JEHFM47DYY3S57	10/03/2025	FR0014000MR3	43,093	47.3135	CEUX
EUROFINS	529900JEHFM47DYY3S57	10/03/2025	FR0014000MR3	127	47.8500	AQEU
EUROFINS	529900JEHFM47DYY3S57	11/04/2025	FR0014000MR3	123,180	47.1516	XPAR
EUROFINS	529900JEHFM47DYY3S57	11/04/2025	FR0014000MR3	65,710	47.1966	CEUX
EUROFINS	529900JEHFM47DYY3S57	11/04/2025	FR0014000MR3	5,110	47.1921	TQEX
EUROFINS	529900JEHFM47DYY3S57	11/04/2025	FR0014000MR3	6,000	47.1954	AQEU
			TOTAL	937,475	46.9760

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

View source version on businesswire.com: https://www.businesswire.com/news/home/20250414874270/en/

Contacts:

Eurofins

Zeit	Aktuelle Nachrichten
Mi	Eurofins Delivers 6.9% Revenue Growth in Q1 2025 and Continues to Make Progress on the Build Out of Its Best-in-Class, Fully Digital Global Laboratory Network	Regulatory News: The Eurofins (Paris:ERF) network of companies achieved solid growth in most business lines in Q1 2025: Reported revenues in Q1 2025 totalled €1,767m, an increase of 6.9%... ► Artikel lesen
Di	Eurofins: Purchases of Own Shares From April 14th to April 17th 2025	Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen
14.04.	Eurofins: Purchases of Own Shares From April 7th to April 11th 2025	Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen
10.04.	Research and Markets: Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com	The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The Europe... ► Artikel lesen
09.04.	Eurofins Scientific SE: Eurofins Announces the Cancellation of 10.8m Repurchased Shares	Regulatory News: Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 10,818,183 shares, representing... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Eurofins Delivers 6.9% Revenue Growth in Q1 2025 and Continues to Make Progress on the Build Out of Its Best-in-Class, Fully Digital Global Laboratory Network

Regulatory News: The Eurofins (Paris:ERF) network of companies achieved solid growth in most business lines in Q1 2025: Reported revenues in Q1 2025 totalled €1,767m, an increase of 6.9%...
► Artikel lesen

Eurofins: Purchases of Own Shares From April 14th to April 17th 2025

Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total...
► Artikel lesen

14.04.

Eurofins: Purchases of Own Shares From April 7th to April 11th 2025

Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total...
► Artikel lesen

10.04.

Research and Markets: Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com

The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
► Artikel lesen

09.04.

Eurofins Scientific SE: Eurofins Announces the Cancellation of 10.8m Repurchased Shares

Regulatory News: Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 10,818,183 shares, representing...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
EUROFINS SCIENTIFIC SE	54,16	-0,59 %

Unternehmen / Aktien

Kurs

EUROFINS SCIENTIFIC SE

54,16

-0,59 %

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche